Key Takeaways
- Gender selection for non-medical reasons is prohibited in Thailand under Medical Council regulations
- Gender selection IS permitted to prevent sex-linked genetic disorders like hemophilia
- PGT (Pre-implantation Genetic Testing) reveals embryo sex with over 99% accuracy
- PGT results are typically available within 7-10 days after embryo biopsy
- PGT also screens for chromosomal abnormalities, reducing miscarriage risk
- Bangkok Central Clinic offers PGT-A, PGT-M, and PGT-SR services with experienced specialists
Can you choose the gender of your baby through fertility treatment? It’s one of the most common questions prospective parents ask when exploring their options at an IVF clinic. Thailand has regulations regarding the use of accurate embryo sex identification technology. It’s crucial to understand these guidelines before embarking on your fertility journey.
This guide explains how gender determination works during IVF, what Thai law permits, and how genetic testing can support a healthy pregnancy.
How Gender Selection Works with IVF
Gender is determined through Pre-implantation Genetic Testing (PGT), a laboratory procedure performed alongside IVF treatment. Here’s how the process works:
- After fertilization, embryos develop in the laboratory for 5-6 days until they reach the blastocyst stage
- A few cells (typically 3-10) are carefully removed from each embryo’s outer layer
- These cells are analyzed using advanced genetic sequencing technology
- The testing reveals both chromosomal health AND sex chromosomes (XX for female, XY for male)
So when do you find out the gender of a baby through this method? PGT results are typically available within 7-10 days after the embryo biopsy, well before any embryo transfer occurs. This scientific approach offers over 99% accuracy in determining embryo sex, far more reliable than any natural method.
Thailand’s Laws on Gender Selection
The Medical Council of Thailand has established clear guidelines regarding IVF treatment and gender selection:
What Is NOT Permitted:
- Gender selection for non-medical reasons (often called “family balancing”) is prohibited
- Using PGT solely to choose a baby’s sex based on personal preference violates the Medical Facility Act B.E. 2541
What IS Permitted:
- Gender selection for medical purposes to prevent sex-linked genetic disorders
- Conditions like hemophilia, Duchenne muscular dystrophy, and certain X-linked disorders qualify
- When family history indicates risk, identifying embryo sex becomes medically necessary
Patients should always consult with qualified fertility specialists to ascertain if they meet medical criteria. Before performing these procedures, licensed clinics are required to adhere to stringent ethical standards and obtain certification from the Royal Thai College of Obstetricians and Gynecologists.
What PGT Can Do for Your IVF Journey
While elective gender selection isn’t available in Thailand, PGT offers significant benefits that can dramatically improve your pregnancy outcomes:
Screen for chromosomal abnormalities (PGT-A)
- Detects aneuploidy (incorrect chromosome numbers)
- Significantly reduces miscarriage risk
- Especially valuable for women over 35
Detect single-gene disorders (PGT-M)
- Identifies inherited conditions like thalassemia, cystic fibrosis, and sickle cell disease
- Helps families avoid passing genetic conditions to children
Identify structural chromosome issues (PGT-SR)
- Detects translocations and inversions
- Recommended for couples with a recurrent miscarriage history
Select the healthiest embryos
- Increases implantation success rates
- Improves overall IVF outcomes
- Provides peace of mind throughout your journey
How Bangkok Central Clinic Supports Your Journey
Navigating fertility treatment, especially when genetic concerns are involved, can feel overwhelming. At Bangkok Central Clinic, we focus on understanding your unique situation and guiding you through every step with clarity and compassion.
Our clinic’s specialist team includes experienced fertility doctors like Dr. Tanut Jerachotechueantaveechai, alongside skilled embryologists who work together to create personalized treatment plans. Our laboratory team uses advanced technology, including Next-Generation Sequencing (NGS) and Fluorescent in Situ Hybridization (FISH), to deliver accurate genetic analysis while carefully preserving embryo viability.
When it comes to genetic testing, Bangkok Central Clinic offers the full range of PGT services. PGT-A screens embryos for chromosomal abnormalities, helping reduce miscarriage risk. PGT-M detects specific inherited conditions like thalassemia or cystic fibrosis, which is particularly important for families with known genetic histories. PGT-SR identifies structural chromosome rearrangements for couples who have experienced recurrent pregnancy loss.
What many patients appreciate most is the honest, straightforward guidance. Our team takes time to explain what’s medically possible, what Thai law permits, and what realistic outcomes look like for your specific circumstances. For international patients, multilingual support helps ensure nothing gets lost in translation during such an important process.
Learn more about PGT services at Bangkok Central Clinic →
Start Your Conversation with a Fertility Specialist
While elective gender selection isn’t permitted in Thailand, Pre-implantation Genetic Testing offers proven benefits for building a healthy family. From reducing miscarriage risk to screening for inherited conditions, PGT helps you approach parenthood with greater confidence.
Book a consultation at Bangkok Central Clinic to discuss how genetic testing can support your family-building goals, within the ethical and legal guidelines that protect both you and your future child.
References:
- Can you choose the gender of your baby? Natural vs. technology‑based methods to choose the baby’s gender. (2025, March 29). Beyond IVF. Retrieved January 26, 2026, from https://www.beyondivf.com/en/articles/can‑we‑choose‑baby‑gender
- Inside Thailand’s gender selection clinics: IVF options, costs & hopeful journeys. MedicareVacation.com. Retrieved January 26, 2026, from https://www.medicarevacation.com/inside‑thailands‑gender‑selection‑clinics‑ivf‑options‑costs‑hopeful‑journeys/
Frequently Asked Questions
Q: Can you choose the gender of your baby through IVF in Thailand?
A: Gender selection for personal preference is not permitted under Thai law. However, if you have a family history of sex-linked genetic disorders, such as hemophilia or Duchenne muscular dystrophy, gender identification may be allowed as part of medical screening to prevent passing these conditions to your child.
Q: During IVF with PGT, when do you find out the gender of a baby?
A: PGT results, including chromosomal sex (XX or XY), are typically available within 7-10 days after embryo biopsy. This occurs before any embryo transfer, allowing time for informed decision-making with your doctor.
Q: What is the difference between PGT and PGD?
A: PGD (Pre-implantation Genetic Diagnosis) is an older term focused on diagnosing known single-gene disorders. PGT (Pre-implantation Genetic Testing) is the broader, modern term covering chromosomal screening (PGT-A), single-gene testing (PGT-M), and structural rearrangement detection (PGT-SR).
Q: Does PGT guarantee a successful pregnancy?
A: PGT significantly improves IVF success rates by helping select chromosomally healthy embryos, but no fertility treatment guarantees pregnancy. Success depends on factors including maternal age, egg quality, and overall health. However, many patients experience higher implantation rates and reduced miscarriage risk with PGT.
Q: Is PGT safe for the embryo?
A: Yes. Cells are taken from the trophectoderm (the outer layer that becomes the placenta), not from the inner cell mass that develops into the baby. Expert embryologists use advanced techniques designed to preserve embryo viability while providing accurate genetic information.
Q: Who should consider PGT during IVF?
A: PGT is recommended for couples with recurrent miscarriage history, women of advanced maternal age (35+), patients with multiple failed IVF cycles, carriers of known genetic disorders, and families with sex-linked genetic disease history.
